St Jude completes Velocimed acquisition:
This article was originally published in Clinica
Executive Summary
St Jude Medical has completed its acquisition of interventional cardiology firm Velocimed. It is paying $74m in cash plus contingent payments, and will record a special charge of about $13.8m in the second quarter related to in-process R&D. The deal was announced on February 15, and was for $82.5m in total, minus an estimated $8.5m in cash at Velocimed, of Maple Grove, Minnesota.